In the long and often dispiriting quest to cure cancer, the 1998 approval of the drug Herceptin was a tremendously hopeful moment. This drug for breast cancer was the first to use a tumor-specific ...
Hua Medicine is developing potentially disease-modifying therapeutics for type 2 diabetes, driven by mechanisms in the glucose homeostasis process. Having launched dorzagliatin in China in 2022, the ...